A detailed history of Legal & General Group PLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 839 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
839
Previous 839 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
N/A
-85 Reduced 9.2%
839 $0
Q1 2023

May 15, 2023

BUY
N/A
924 New
924 $0

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.